CHOI, YOUN WOONGKR,최연웅,HA, DAE CHULKR,하대철,KWON, IN HOKR,권인호,KIM, AH YOUNGKR,김아영,SONG, HEE YONGKR,송희용,JUNG, RAE HOONKR,정래훈,CHOI, BO RAMKR,최보람
申请号:
KR1020160029881
公开号:
KR1020170106126A
申请日:
2016.03.11
申请国别(地区):
KR
年份:
2017
代理人:
摘要:
One embodiment of the present invention provides a pharmaceutical composition for alleviating or treating ischemic symptoms of chronic total occlusion, which comprises (±)-2-[2-(3-carboxypropionyloxy)-3-dimethylaminopropoxy]-3&prime-methoxybibenzyl hydrochloride as an effective component.COPYRIGHT KIPO 2017본 발명의 일 양상은 유효성분으로서 (±)-2-[2-(3-카르복시프로피오닐옥시)-3-디메틸아미노프로폭시]-3-메톡시비벤질 하이드로클로라이드를 포함하는, 만성 동맥폐색증에 의한 허혈성 증상 개선 또는 치료용 약학 조성물을 제공한다.